Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Prevalence, Clinical and Molecular Features, and Prognostic Value of Tetraploidy/Near-Tetraploidy in Patients with Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 3454–3455.

https://doi.org/10.1182/blood-2022-166271

Published: 2022

Journal Articles

Mutant TET2 Allele Dosage Affects Response to 5-Azacitidine in Acute Myeloid Leukemia

Blood (2019) 134 (Supplement_1): 113.

https://doi.org/10.1182/blood-2019-123047

Published: 2019

Journal Articles

Prospective Comparative Evaluation of Flow Cytometric Scores Regarding the Sensitivity and Specificity As Well As Prognosis in 616 Patients with Proven or Suspected MDS

Uta Oelschlaegel, Lorenz Oelschlaeger, Brigitte Mohr, Katja Sockel, MD, Martin Bornhäuser, MD, Uwe Platzbecker

Blood (2018) 132 (Supplement 1): 1816.

https://doi.org/10.1182/blood-2018-99-111454

Published: 2018

Journal Articles

PPM1D Mutations Are Rare in De Novo and Therapy-Related Acute Myeloid Leukemia

Mutlu Kartal-Kaess, MD, Tilmann Bochtler, Bianca Kraft, PhD, Michael Kirsch, Bettina Maier, PhD, Friedrich Stoelzel, Brigitte Mohr, Michael Kramer, M.Sc., Christoph Rollig, MD MSC, Christian Thiede, MD, Martin Bornhäuser, Gerhard Ehninger, MD, Carsten Müller-Tidow, Alwin Krämer, MD

Blood (2018) 132 (Supplement 1): 1472.

https://doi.org/10.1182/blood-2018-99-118566

Published: 2018

Journal Articles

Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia

Tilmann Bochtler, Martin Granzow, Friedrich Stölzel, Christina Kunz, Brigitte Mohr, Mutlu Kartal-Kaess, Katrin Hinderhofer, Christoph E. Heilig, Michael Kramer, Christian Thiede, Volker Endris, Martina Kirchner, Albrecht Stenzinger, Axel Benner, Martin Bornhäuser, Gerhard Ehninger, Anthony D. Ho, Anna Jauch, Alwin Krämer

Blood (2017) 129 (10): 1333–1342.

https://doi.org/10.1182/blood-2016-09-738161

Published: 2017

Includes: Supplemental data

Journal Articles

Marker Chromosomes Can Arise from Chromothripsis and Predict Adverse Prognosis in Acute Myeloid Leukemia

Tilmann Bochtler, MD, Martin Granzow, PhD, Friedrich Stölzel, MD, Christina Kunz, PhD, Brigitte Mohr, PhD, Mutlu Kartal-Kaess, MD, Johannes W.G. Janssen, PhD, Christoph E. Heilig, MD, Michael Kramer, MSc, Christian Thiede, MD, Axel Benner, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Anthony D. Ho, MD, Anna Jauch, PhD, Alwin Krämer, MD

Blood (2016) 128 (22): 2869.

https://doi.org/10.1182/blood.V128.22.2869.2869

Published: 2016

Journal Articles

Flow Cytometric Response Monitoring in MDS with Del(5q) Using a Simple 5-Parameter-Score - an Elnet Imds-Flow Experience

Uta Oelschlaegel, PhD, Theresia M. Westers, PhD, Brigitte Mohr, PhD, Ulrika Johansson, PhD, Dolores Subira, PhD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Arjan A van de Loosdrecht, MD PhD, Uwe Platzbecker, MD

Blood (2016) 128 (22): 3179.

https://doi.org/10.1182/blood.V128.22.3179.3179

Published: 2016

Journal Articles

Implementation of Diagnostic Flow Cytometry Allows for the Dissection of Age Related Loss of Y Chromosome from Myelodysplastic Syndrome (MDS)

Uta Oelschlaegel, PhD, Brigitte Mohr, PhD, Katja Sockel, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Uwe Platzbecker

Blood (2016) 128 (22): 5531.

https://doi.org/10.1182/blood.V128.22.5531.5531

Published: 2016

Journal Articles

Adverse Prognosis in Acute Myeloid Leukemia with Abnormality Abn(3q): Does EVI1 Matter?

Blood (2015) 126 (23): 1309.

https://doi.org/10.1182/blood.V126.23.1309.1309

Published: 2015

Journal Articles

Randomized Comparison of Intermediate-Dose Cytarabine Plus Mitoxantrone (IMA) Versus Standard-Dose Cytarabine Plus Daunorubicin (DA) for Induction Therapy in AML Patients >60 Years. Results from the SAL 60+ Trial

Blood (2015) 126 (23): 222.

https://doi.org/10.1182/blood.V126.23.222.222

Published: 2015

Journal Articles

Differential Distribution of Clonal Hematopoiesis in Flow-Sorted Subpopulations of Patients with Myelodysplastic Syndromes (MDS)

Maximilian Alexander Röhnert, Uwe Platzbecker, MD, Uta Oelschlägel, PhD, Christian Thiede, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Brigitte Mohr, PhD

Blood (2014) 124 (21): 4626.

https://doi.org/10.1182/blood.V124.21.4626.4626

Published: 2014

Journal Articles

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Jan M. Middeke, Min Fang, Jan J. Cornelissen, Brigitte Mohr, Frederick R. Appelbaum, Michael Stadler, Jaime Sanz, Herrad Baurmann, Gesine Bug, Kerstin Schäfer-Eckart, Ute Hegenbart, Tilmann Bochtler, Christoph Röllig, Friedrich Stölzel, Roland B. Walter, Gerhard Ehninger, Martin Bornhäuser, Bob Löwenberg, Johannes Schetelig

Blood (2014) 123 (19): 2960–2967.

https://doi.org/10.1182/blood-2013-12-544957

Published: 2014

Includes: Supplemental data

Journal Articles

A Distinct Immunophenotypic Profile Of Del(5q) MDS Allows For Fast Monitoring Of Response To Treatment With Lenalidomide Or Azacitidine

Uta Oelschlaegel, PhD, Brigitte Mohr, PhD, Michael Kramer, PhD, Stefani Parmentier, MD, Katja Sockel, MD, Christian Thiede, MD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Uwe Platzbecker, MD, PhD

Blood (2013) 122 (21): 2780.

https://doi.org/10.1182/blood.V122.21.2780.2780

Published: 2013

Journal Articles

Karyotypic Complexity In Acute Myeloid Leukemia In The Context Of Adverse Prognosis

Friedrich Stölzel, MD, Brigitte Mohr, PhD, Michael Kramer, PhD, Christoph Röllig, MD, Tilmann Bochtler, MD, Alwin Krämer, MD, Uta Oelschlägel, PhD, Jan Moritz Middeke, MD, Uwe Platzbecker, MD, PhD, Markus Schaich, MD, Johannes Schetelig, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD

Blood (2013) 122 (21): 489.

https://doi.org/10.1182/blood.V122.21.489.489

Published: 2013

Journal Articles

TP53 Mutations In Patients With High-Risk Acute Myeloid Leukemia Treated With Allogeneic Hematopoietic Stem Cell Transplantation

Jan Moritz Middeke, MD, Silvia Herold, PhD, Elke Rücker-Braun, PhD, Brigitte Mohr, Wolfgang E. Berdel, MD, Martin Kaufmann, MD, Kerstin Schäfer-Eckart, MD, Claudia D. Baldus, MD, PhD, Reingard Stuhlmann, MD, Falk Heidenreich, PhD, Friedrich Stölzel, MD, Christoph Röllig, MD, Uwe Platzbecker, MD, PhD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Christian Thiede, MD, Johannes Schetelig, MD, M. Sc

Blood (2013) 122 (21): 711.

https://doi.org/10.1182/blood.V122.21.711.711

Published: 2013

Journal Articles

Outcome Of Patients With Abnl(17p) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Jan Moritz Middeke, MD, Min Fang, MD, PhD, Jan Cornelissen, MD, PhD, Frederick R. Appelbaum, MD, Brigitte Mohr, Michael Stadler, MD, Miguel Sanz, Herrad Baurmann, MD, Gesine Bug, MD, PhD, Kerstin Schäfer-Eckart, MD, Ute Hegenbart, MD, Tilmann Bochtler, MD, Friedrich Stölzel, MD, Roland B. Walter, MD, PhD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Bob Löwenberg, MD, PhD, Johannes Schetelig, MD, M. Sc

Blood (2013) 122 (21): 303.

https://doi.org/10.1182/blood.V122.21.303.303

Published: 2013

Journal Articles

The Prognostic Impact of the Revised IPSS Cytogenetic Scoring System for Patients with MDS Allows a Risk-Stratification for Patients with MDS-Derived Acute Myeloid Leukemia

Friedrich Stölzel, MD, Michael Kramer, Brigitte Mohr, PhD, Martin Wermke, MD, Martin Bornhäuser, MD, Gerhard Ehninger, Markus Schaich, MD, Uwe Platzbecker, MD

Blood (2012) 120 (21): 1715.

https://doi.org/10.1182/blood.V120.21.1715.1715

Published: 2012

Journal Articles

Acute Erythroleukemia Morphology Does Not Confer an Unfavourable Prognosis in Itself. Results of a Subgroup Analysis of the Prospective Randomized AML96-, AML2003 and AML60+ Studies of the Study Alliance Leukemia (SAL)

Stefani Parmentier, MD, Michael Kramer, Katharina Koch, Brigitte Mohr, PhD, Christian Klesse, Christian Thiede, Christoph Röllig, Mathias Hänel, MD, Norbert Schmitz, MD, Kerstin Schäfer-Eckart, Walter E. Aulitzky, Wolfgang E. Berdel, MD, Hubert Serve, Prof. Dr. med., Stefan W. Krause, Jiri Mayer, MD, Martin Bornhäuser, MD, Gerhard Ehninger, Markus Schaich, MD

Blood (2012) 120 (21): 1481.

https://doi.org/10.1182/blood.V120.21.1481.1481

Published: 2012

Journal Articles

A Unique Case of a Donor Cell Acute Myeloid Leukemia Reveals Complex Kinetics of Mutations and Evolution of the Disease

Sylvia Herold, PhD, Matthias Kuhn, Uwe Platzbecker, MD, Stange Thoralf, Jörgen Radke, MD, Caroline Heiderich, Lange Thoralf, MD, Kerstin Gutsche, MD, Johannes Schetelig, Stefani Parmentier, MD, Brigitte Mohr, PhD, Markus Schaich, MD, Hubert Serve, Prof. Dr. med., Christian H. Brandts, Martin Bornhäuser, Gerhard Ehninger, Christian Thiede

Blood (2012) 120 (21): 886.

https://doi.org/10.1182/blood.V120.21.886.886

Published: 2012

Journal Articles

Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−

Jan M. Middeke, Dietrich Beelen, Michael Stadler, Gudrun Göhring, Brigitte Schlegelberger, Herrad Baurmann, Gesine Bug, Frauke Bellos, Brigitte Mohr, Stefanie Buchholz, Rainer Schwerdtfeger, Hans Martin, Ute Hegenbart, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig

Blood (2012) 120 (12): 2521–2528.

https://doi.org/10.1182/blood-2012-03-417972

Published: 2012

Includes: Supplemental data

NARROW

Prevalence, Clinical and Molecular Features, and Prognostic Value of Tetraploidy/Near-Tetraploidy in Patients with Acute Myeloid Leukemia

Mutant TET2 Allele Dosage Affects Response to 5-Azacitidine in Acute Myeloid Leukemia

Prospective Comparative Evaluation of Flow Cytometric Scores Regarding the Sensitivity and Specificity As Well As Prognosis in 616 Patients with Proven or Suspected MDS

PPM1D Mutations Are Rare in De Novo and Therapy-Related Acute Myeloid Leukemia

Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia

Marker Chromosomes Can Arise from Chromothripsis and Predict Adverse Prognosis in Acute Myeloid Leukemia

Flow Cytometric Response Monitoring in MDS with Del(5q) Using a Simple 5-Parameter-Score - an Elnet Imds-Flow Experience

Implementation of Diagnostic Flow Cytometry Allows for the Dissection of Age Related Loss of Y Chromosome from Myelodysplastic Syndrome (MDS)

Adverse Prognosis in Acute Myeloid Leukemia with Abnormality Abn(3q): Does EVI1 Matter?

Randomized Comparison of Intermediate-Dose Cytarabine Plus Mitoxantrone (IMA) Versus Standard-Dose Cytarabine Plus Daunorubicin (DA) for Induction Therapy in AML Patients >60 Years. Results from the SAL 60+ Trial

Differential Distribution of Clonal Hematopoiesis in Flow-Sorted Subpopulations of Patients with Myelodysplastic Syndromes (MDS)

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

A Distinct Immunophenotypic Profile Of Del(5q) MDS Allows For Fast Monitoring Of Response To Treatment With Lenalidomide Or Azacitidine

Karyotypic Complexity In Acute Myeloid Leukemia In The Context Of Adverse Prognosis

TP53 Mutations In Patients With High-Risk Acute Myeloid Leukemia Treated With Allogeneic Hematopoietic Stem Cell Transplantation

Outcome Of Patients With Abnl(17p) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

The Prognostic Impact of the Revised IPSS Cytogenetic Scoring System for Patients with MDS Allows a Risk-Stratification for Patients with MDS-Derived Acute Myeloid Leukemia

Acute Erythroleukemia Morphology Does Not Confer an Unfavourable Prognosis in Itself. Results of a Subgroup Analysis of the Prospective Randomized AML96-, AML2003 and AML60+ Studies of the Study Alliance Leukemia (SAL)

A Unique Case of a Donor Cell Acute Myeloid Leukemia Reveals Complex Kinetics of Mutations and Evolution of the Disease

Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only